Bibliography
- Skeiky YA, Sadoff JC. Advances in tuberculosis vaccine strategies. Nat Rev Microbiol 2006;4(6):469-76
- Middlebrook G. Immunological aspects of airborne infection: reactions to inhaled antigens. Bacteriol Rev 1961;25:33-146
- Rosenthal SR, Mcenery JT, Raisys N. Aerogenic BCG vaccination against tuberculosis in animal and human subjects. J Asthma Res 1968;5(4):309-23
- Rosenthal SR. Aerosol Vaccination. In: Rosenthal SR, editor, BCG vaccine: tuberculosis-cancer. PSG Publishing Company, Inc. Littleton, Massachusetts; 1980. p. 170-2
- Chougule MB, Padhi BK, Jinturkar KA, Misra A. Development of dry powder inhalers. Recent Patents Drug Deliv Formulation 2007;1(1):11-21
- Licalsi C, Christensen T, Bennett JV, et al. Dry powder inhalation as a potential delivery method for vaccines. Vaccine 1999;17(13-14):1796-803
- Frijlink HW, De Boer AH. Dry powder inhalers for pulmonary drug delivery. Expert Opin Drug Deliv 2004;1(1):67-86
- Kallenius G, Pawlowski A, Brandtzaeg P, Svenson S. Should a new tuberculosis vaccine be administered intranasally? Tuberculosis 2007;87(4):257-66
- Scheuch G, Kohlhaeufl MJ, Brand P, Siekmeier R. Clinical perspectives on pulmonary systemic and macromolecular delivery. Adv Drug Deliv Rev 2006;58(9-10):996-1008
- Lombry C, Marteleur A, Arras M, et al. Local and Systemic immune responses to intratracheal instillation of antigen and DNA vaccines in mice. Pharm Res 2004;21(1):127-35
- Greenway TE, Eldridge JH, Ludwig G, et al. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine. Vaccine 1998;16(13):1314-23
- Eyles JE, Williamson ED, Spiers ID, Alpar HO. Protection studies following bronchopulmonary and intramuscular immunisation with Yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy. Vaccine 2000;18(28):3266-71
- Sabin AB. Immunization against measles by aerosol. Rev Infect Dis 1983;5(3):514-23
- Waldman RH, Mann JJ, Small PA. Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccine. Jama J Am Med Assoc 1969;207:520-4
- Wong Y-L, Sampson S, Germishuizen WA, et al. Drying a tuberculosis vaccine without freezing. Proc Natl Acad Sci USA 2007;104:2591-5
- Edwards DA, Hanes J, Caponetti G, et al. Large porous particles for pulmonary drug delivery. Science 1997;276:1868-72
- Shoyele SA, Cawthorne S. Particle engineering techniques for inhaled biopharmaceuticals. Adv Drug Deliv Rev 2006;58:1009-29
- Garcia-Contreras L, Wong Y-L, Muttil P, et al. Immunization by a bacterial aerosol. Proc Natl Acad Sci USA 2008;105(12):4656-60
- Lu DM, Hickey AJ. Pulmonary vaccine delivery. Expert Rev Vaccines 2007;6(2):213-26
- Seville PC, Kellaway IW, Birchall JC. Preparation of dry powder dispersions for non-viral gene delivery by freeze-drying and spray-drying. J Gene Med 2002;4:428-37
- Irngartinger M, Camuglia V, Damm M, et al. Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing. Eur J Pharm Biopharm 2004;58(1):7-14
- Shoyele SA, Slowey A. Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery. Int J Pharm 2006;314(1):1-8
- Mumenthaler M, Hsu CC, Pearlman R. Feasibility study on spray-drying protein pharmaceuticals: recombinant human growth hormone and tissue-type plasminogen activator. Pharm Res 1994;11:12-20
- Skyler JS. Pulmonary Insulin Delivery – State of the art 2007. Diabetes Technol Ther 2007;9(s1):1-3
- Lian WC, Hsiao HC, Chou CC. Survival of bifidobacteria after spray-drying. Int J Food Microbiol 2002;74:79-86
- Murillo M, Gamazo C, Goni MM, et al. Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis. Int J Pharm 2002;242(1-2):341-4
- Maa Y-F, Zhao L, Payne LG, Chen D. Stabilization of alum-adjuvanted vaccine dry powder formulations: Mechanism and application. J Pharm Sci 2003;92:319-32
- Bivas-Benita M, Van Meijgaarden KE, Franken K, et al. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis. Vaccine 2004;22(13-14):1609-15
- Bosquillon C, Preat V, Vanbever R. Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats. J Control Release 2004;96(2):233-44
- Li H-Y, Neill H, Innocent R, et al. Enhanced dispersibility and deposition of spray-dried powders for pulmonary gene therapy. J Drug Target 2003;11(7):425-532
- Bosquillon C, Lombry C, Preat V, Vanbever R. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J Control Release 2001;70(3):329-39
- Codrons V, Vanderbist F, Verbeeck R, et al. Systemic delivery of parathyroid hormone using inhalation dry powder in rats. J Pharm Sci 2003;92:938-50
- Tsapis N, Bennett D, Jackson B, et al. Trojan particles: Large porous carriers of nanoparticles for drug delivery. Proc Natl Acad Sci USA 2002;99(19):12001-5
- Sham JO-H, Zhang Y, Finlay WH, et al. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung. Int J Pharm 2004;269(2):457-67
- Alpar HO, Somavarapu S, Atuah KN, Bramwell V. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv Drug Deliv Rev 2005;57(3):411-30
- Maa YF, Nguyen PA, Andya JD, et al. Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders. Pharm Res 1998;15:768-75
- Niven R. Dry powder formulations for inhalation. Adv Drug Deliv Rev 1997;26(Special issue):1-67
- Pitcairn GR, Lankinen T, Seppala O-P, Newman SP. Pulmonary drug delivery from the Taifun dry powder inhaler is relatively independent of the patient's inspiratory effort. J Aerosol Med 2000;13(2):97-104
- Everard ML. Inhalation therapy for infants. Adv Drug Deliv Rev 2003;55(7):869-78